Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.730
-0.090-1.15%
Volume:124.28M
Turnover:959.16M
Market Cap:89.04B
PE:19.15
High:7.890
Open:7.820
Low:7.620
Close:7.820
Loading ...

CSPC Pharmaceutical Group Ltd. Receives Third FDA Fast Track Designation for CPO301 in Treating Advanced NSCLC

Reuters
·
19 May

BRIEF-CSPC Pharmaceutical Says Cpo301 Granted Third Fast Track Designation By U.S. FDA

Reuters
·
19 May

CSPC Pharmaceutical - Cpo301 Granted Third Fast Track Designation by U.S. FDA for Treatment of Adult Patients With Nsclc

THOMSON REUTERS
·
19 May

CSPC Pharmaceutical Group Ltd. Announces Clinical Trial Approval in China and U.S. for JMT106, a Promising Bispecific Fusion Protein Drug Targeting Advanced Solid Tumors

Reuters
·
19 May

CSPC Pharmaceutical - Jmt106 (Bispecific Fusion Protein Drug) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
19 May

CSPC Pharmaceutical Grants Cipla US Marketing Rights to Cancer Drug

MT Newswires Live
·
15 May

BRIEF-CSPC Pharmaceutical Signs Exclusive License Agreement With Cipla USA

Reuters
·
15 May

CSPC Pharmaceutical Group Secures Exclusive Licensing Deal with Cipla USA for Irinotecan Liposome Injection

Reuters
·
15 May

CSPC Pharmaceutical - Group Will Receive an Upfront Payment of US$15 Mln

THOMSON REUTERS
·
15 May

CSPC Pharmaceutical - Exclusive License Agreement With Cipla USA, Inc. for Irinotecan Liposome Injection

THOMSON REUTERS
·
15 May

CSPC Pharmaceutical - Eligible to Receive Potential Additional Commercial Sales Milestone Payments of up to US$1,025 Mln

THOMSON REUTERS
·
15 May

CSPC Pharmaceutical Gets China Approval for Acid Blockers

MT Newswires Live
·
13 May

BRIEF-Cspc Pharmaceutical Says Vonoprazan Fumarate Tablets Obtains Drug Registration Approval

Reuters
·
12 May

CSPC Pharmaceutical Gets US FDA Nod for Cardiac Drug Trial

MT Newswires Live
·
12 May

CSPC Pharmaceutical - Syh2046 Tablets Obtains Clinical Trial Approval in U.S. by FDA

THOMSON REUTERS
·
09 May

CSPC Pharmaceutical Gets US FDA Nod for Metabolism Disease Drug Trial

MT Newswires Live
·
02 May

CSPC Pharmaceutical's Phase 2/3 trial for Anti-Cancer Drug Meets Primary Endpoints

MT Newswires Live
·
02 May

CSPC Pharmaceutical Group Ltd. Receives U.S. FDA Approval for Clinical Trials of JMT202, an Innovative Anti-Beta Klotho Monoclonal Antibody Drug

Reuters
·
02 May

BRIEF-CSPC Pharmaceutical's JMT202 Obtains Clinical Trial Approval In U.S.

Reuters
·
02 May

BRIEF-Ob Holdings Says Unit Entered Into Letters Of Intent With Units of CSPC Pharmaceutical Group

Reuters
·
02 May